Psychiatry in Van Nuys, CA
17 verified psychiatry doctors in Van Nuys.
Psychiatrists are physicians who diagnose and treat mental health conditions, including through medication management.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Andrew Wang, MD
Psychiatry
CMS Open Payments· $170.32 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$170.32
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total ranks around the 88th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Andrew Wang do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ofik Babayan, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Marc Nehorayan, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Irene Chuang, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Anthony Schnurer, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Janet Martin, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. James Rosenberg, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Stacey Bernstein, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Sara Kaner, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Cyril Mathai, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Maged Botros, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Vandana Chopra, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Yon Park, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Omotola Tsarumi, MD
Psychiatry
CMS Open Payments· $4,222 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$4,222
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Omotola Tsarumi do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Andrew Davidowitz, MD
Psychiatry
CMS Open Payments· $16.62 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$16.62
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total ranks around the 77th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Andrew Davidowitz do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Diego Centeno, MD
Psychiatry
CMS Open Payments· $105.15 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$105.15
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Diego Centeno do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Rachel Bland, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.